Carol Schafer - Jun 3, 2021 Form 3 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
James Basta, Attorney-in-fact for Carol Schafer
Stock symbol
KURA
Transactions as of
Jun 3, 2021
Transactions value $
$0
Form type
3
Date filed
6/4/2021, 04:24 PM
Previous filing
May 14, 2021
Next filing
Jun 10, 2021

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.